Innovative Research Focus The Institute for Protein Innovation specializes in developing synthetic antibodies and deep protein expertise, making it a prime partner for companies seeking novel biotechnological tools and collaborations in antibody discovery and therapeutic target identification.

Strategic Partnerships Recent collaborations with Addgene and the launch of novel nanobody scaffolds highlight the organization’s openness to forming strategic alliances, presenting opportunities for joint ventures, technology licensing, or distribution collaborations.

Funding & Growth With an estimated revenue between $25 million and $50 million and ongoing philanthropic support, the institute demonstrates strong financial stability, which can facilitate investment in new technologies, research expansion, or product commercialization efforts.

Recent Program Expansions The launch of the Springer-Lu Postdoctoral Fellowship and new antibody libraries indicates an active growth in research capabilities, opening doors for collaborations in cutting-edge protein science and early-stage biotech innovations.

Leadership & Expertise Led by experienced executives like President and CEO Kenneth Fasman, the organization’s leadership team is well-positioned to explore commercial partnerships, licensing opportunities, and joint research initiatives to accelerate technology transfer and market entry.